CNS immune privilege: hiding in plain sight
暂无分享,去创建一个
B. Melchior | Jonathan M. Doose | M. Carson | C. Schmid | C. Ploix | Monica J. Carson | Jonathan M. Doose | Benoit Melchior | Christoph D. Schmid | Corinne C. Ploix
[1] A. Minagar,et al. Serum from patients with multiple sclerosis downregulates occludin and VE-cadherin expression in cultured endothelial cells , 2003, Multiple sclerosis.
[2] V. ter meulen,et al. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[3] C. Teunissen,et al. Macrophages and neurodegeneration , 2005, Brain Research Reviews.
[4] H. D. Liggitt,et al. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. , 1997, Journal of immunology.
[5] Wei Zhang,et al. Pten Regulates Neuronal Arborization and Social Interaction in Mice , 2006, Neuron.
[6] R. Swanborg. Experimental autoimmune encephalomyelitis in the rat: lessons in T‐cell immunology and autoreactivity , 2001, Immunological reviews.
[7] M. Oldstone,et al. Viral Infection of Transgenic Mice Expressing a Viral Protein in Oligodendrocytes Leads to Chronic Central Nervous System Autoimmune Disease , 1996, The Journal of experimental medicine.
[8] M. Carson,et al. The Push-Me Pull-You of T Cell Activation , 2001, Science.
[9] V. Perry,et al. Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS , 2002, Glia.
[10] G. Rosenberg. Matrix metalloproteinases in neuroinflammation , 2002, Glia.
[11] Berislav V. Zlokovic,et al. Neurovascular mechanisms of Alzheimer's neurodegeneration , 2005, Trends in Neurosciences.
[12] J. Parisi,et al. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.
[13] B. Becher,et al. The Clinical Course of Experimental Autoimmune Encephalomyelitis and Inflammation Is Controlled by the Expression of Cd40 within the Central Nervous System , 2001, The Journal of experimental medicine.
[14] M. Carson,et al. A Ligand for the Chemokine Receptor CCR7 Can Influence the Homeostatic Proliferation of CD4 T Cells and Progression of Autoimmunity1 , 2001, The Journal of Immunology.
[15] I. Bechmann,et al. Astrocyte-induced T cell elimination is CD95 ligand dependent , 2002, Journal of Neuroimmunology.
[16] M. Londei,et al. Immune reactivity to glutamic acid decarboxylase 65 in stiff-man syndrome and type 1 diabetes mellitus , 2000, The Lancet.
[17] P. Dore‐Duffy,et al. Role of the CNS microvascular pericyte in the blood‐brain barrier , 1998, Journal of neuroscience research.
[18] K. Suk,et al. The function and integrity of the neurovascular unit rests upon the integration of the vascular and inflammatory cell systems. , 2005, Current neurovascular research.
[19] C. Boz,et al. Matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of matrix metalloproteinase (TIMP-1) in patients with relapsing–remitting multiple sclerosis treated with interferon beta , 2006, Clinical Neurology and Neurosurgery.
[20] A. Bar-Or,et al. Microglial Expression of the B7 Family Member B7 Homolog 1 Confers Strong Immune Inhibition: Implications for Immune Responses and Autoimmunity in the CNS , 2005, The Journal of Neuroscience.
[21] I. Bechmann,et al. Neuroprotection by T-cells depends on their subtype and activation state , 2002, Journal of Neuroimmunology.
[22] J. Streilein,et al. ANTERIOR CHAMBER ASSOCIATED IMMUNE DEVIATION (ACAID): REGULATION, BIOLOGICAL RELEVANCE, AND IMPLICATIONS FOR THERAPY , 2002, International reviews of immunology.
[23] J. Goverman,et al. In Situ Tolerance within the Central Nervous System as a Mechanism for Preventing Autoimmunity , 2000, The Journal of experimental medicine.
[24] L. Lanier,et al. Cloning and characterization of a novel mouse myeloid DAP12‐associated receptor family , 2001, European journal of immunology.
[25] S. Miller,et al. A virus-induced molecular mimicry model of multiple sclerosis , 2001 .
[26] K. Becker,et al. Sensitization to Brain Antigens after Stroke is Augmented by Lipopolysaccharide , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[27] G. Levi,et al. Possible role of microglial prostanoids and free radicals in neuroprotection and neurodegeneration. , 1999, Advances in experimental medicine and biology.
[28] I. Bechmann,et al. Indolamine 2,3‐dioxygenase is expressed in the CNS and down‐regulates autoimmune inflammation , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[29] R. Fujinami,et al. Antibody Association with a Novel Model for Primary Progressive Multiple Sclerosis: Induction of Relapsing‐Remitting and Progressive Forms of EAE in H2S Mouse Strains , 2000, Brain pathology.
[30] H. Weiner,et al. Immunology and immunotherapy of Alzheimer's disease , 2006, Nature Reviews Immunology.
[31] J. Zunt,et al. Autoimmunity due to molecular mimicry as a cause of neurological disease , 2002, Nature Medicine.
[32] S. Baekkeskov,et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase , 1990, Nature.
[33] R. Fujinami,et al. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. , 1985, Science.
[34] M. Carson,et al. Leukocyte Infiltration, But Not Neurodegeneration, in the CNS of Transgenic Mice with Astrocyte Production of the CXC Chemokine Ligand 101 , 2002, The Journal of Immunology.
[35] E. Reinke,et al. Breaking or making immunological privilege in the central nervous system: the regulation of immunity by neuropeptides. , 2006, Immunology letters.
[36] P. Sawchenko,et al. Bone Marrow-Derived Cells that Populate the Adult Mouse Brain Preserve Their Hematopoietic Identity , 2003, The Journal of Neuroscience.
[37] T. Postolache,,et al. Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge , 2005, Neurological research.
[38] C. Barker,et al. Immunologically privileged sites. , 1977, Advances in immunology.
[39] D. Perl,et al. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease , 2004, Journal of neurochemistry.
[40] S. Levison,et al. Neural Stem Cells in the Subventricular Zone Are a Source of Astrocytes and Oligodendrocytes, but Not Microglia , 2003, Developmental Neuroscience.
[41] B. Becher,et al. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis , 2005, Nature Medicine.
[42] S. Miller,et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis , 2005, Nature Medicine.
[43] Y. Matsumoto,et al. Absence of donor-type major histocompatibility complex class I antigen-bearing microglia in the rat central nervous system of radiation bone marrow chimeras , 1987, Journal of Neuroimmunology.
[44] A. Juedes,et al. Resident and Infiltrating Central Nervous System APCs Regulate the Emergence and Resolution of Experimental Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[45] B Bass,et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.
[46] J. Sutcliffe,et al. Balancing function vs. self defense: The CNS as an active regulator of immune responses , 1999, Journal of neuroscience research.
[47] Char-Huei Lai,et al. Critical role of actin in modulating BBB permeability , 2005, Brain Research Reviews.
[48] T. Owens,et al. Naive T lymphocytes traffic to inflamed central nervous system, but require antigen recognition for activation , 2000, European journal of immunology.
[49] P. Medawar. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. , 1948, British journal of experimental pathology.
[50] Burkhard Becher,et al. Brain‐immune connection: Immuno‐regulatory properties of CNS‐resident cells , 2000, Glia.
[51] D. Hinton,et al. Viral Induced Demyelination , 2001, Brain pathology.
[52] Michael T. Heneka,et al. Inflammatory processes in Alzheimer's disease , 2007, Journal of Neuroimmunology.
[53] D. Becker,et al. Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive , 2003, Nature Medicine.
[54] H. Wekerle. Breaking ignorance: the case of the brain. , 2006, Current topics in microbiology and immunology.
[55] B. Weinshenker,et al. Multiple sclerosis: epidemiology, genetics, classification, natural history, and clinical outcome measures. , 2000, Neuroimaging clinics of North America.
[56] O. Salonen,et al. CNS manifestations of Nasu–Hakola disease: A frontal dementia with bone cysts , 2001 .
[57] S. Cullheim,et al. Neuroprotection by Encephalomyelitis: Rescue of Mechanically Injured Neurons and Neurotrophin Production by CNS-Infiltrating T and Natural Killer Cells , 2000, The Journal of Neuroscience.
[58] D. Karussis,et al. Neuroinflammation in multiple sclerosis: Evidence for autoimmune dysregulation, not simple autoimmune reaction , 2006, Clinical Neurology and Neurosurgery.
[59] E. London,et al. The Neuropathology of Autism: A Review , 2005, Journal of neuropathology and experimental neurology.
[60] B. Serafini,et al. Detection of Ectopic B‐cell Follicles with Germinal Centers in the Meninges of Patients with Secondary Progressive Multiple Sclerosis , 2004, Brain pathology.
[61] W. Streit,et al. Role of microglia in the central nervous system's immune response , 2005, Neurological research.
[62] Chris I. De Zeeuw,et al. GATA-3 Is Involved in the Development of Serotonergic Neurons in the Caudal Raphe Nuclei , 1999, The Journal of Neuroscience.
[63] M. Colonna,et al. A Dap12-Mediated Pathway Regulates Expression of Cc Chemokine Receptor 7 and Maturation of Human Dendritic Cells , 2001, The Journal of experimental medicine.
[64] B. Blom,et al. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). , 2000, Science.
[65] E. Masliah,et al. Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor. , 1998, The American journal of pathology.
[66] H. Lassmann,et al. Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the "resistant" Brown Norway rat: disease susceptibility is determined by MHC and MHC-linked effects on the B cell response. , 1999, Journal of immunology.
[67] H. Neumann,et al. Immune Surveillance in the Injured Nervous System: T-Lymphocytes Invade the Axotomized Mouse Facial Motor Nucleus and Aggregate around Sites of Neuronal Degeneration , 1998, The Journal of Neuroscience.
[68] P. Gasque,et al. "Eat me" and "don't eat me" signals govern the innate immune response and tissue repair in the CNS: emphasis on the critical role of the complement system. , 2003, Molecular immunology.
[69] C. Ahlgren,et al. Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor. , 2000, Journal of medicinal chemistry.
[70] R. Ransohoff,et al. Three or more routes for leukocyte migration into the central nervous system , 2003, Nature Reviews Immunology.
[71] C. Janeway,et al. Innate immune recognition and control of adaptive immune responses. , 1998, Seminars in immunology.
[72] V. Perry,et al. The blood-brain barrier and the inflammatory response. , 1997, Molecular medicine today.
[73] B. Engelhardt,et al. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood‐brain barrier suggests their involvement in G‐protein‐dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis , 2002, European journal of immunology.
[74] M. Carson,et al. Immunology. The push-me pull-you of T cell activation. , 2001, Science.
[75] J. Penninger,et al. CD45 regulated signaling pathways. , 2003, Current topics in medicinal chemistry.
[76] B. Melchior,et al. Microglia and the control of autoreactive T cell responses , 2006, Neurochemistry International.
[77] J. Sutcliffe,et al. Microglia stimulate naive T‐cell differentiation without stimulating T‐cell proliferation , 1999, Journal of neuroscience research.
[78] J. Sutcliffe,et al. Disproportionate recruitment of CD8+ T cells into the central nervous system by professional antigen-presenting cells. , 1999, The American journal of pathology.
[79] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials. , 1991, Brain : a journal of neurology.
[80] J. Sutcliffe,et al. Mature microglia resemble immature antigen‐presenting cells , 1998, Glia.
[81] B. Engelhardt,et al. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact , 2005, Acta Neuropathologica.
[82] M. Carson. Microglia as liaisons between the immune and central nervous systems: Functional implications for multiple sclerosis , 2002, Glia.
[83] P. Knopf,et al. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. , 1992, Immunology today.
[84] N. Abbott. Dynamics of CNS Barriers: Evolution, Differentiation, and Modulation , 2005, Cellular and Molecular Neurobiology.
[85] P. Lehmann,et al. Autoreactive T cells promote post-traumatic healing in the central nervous system , 2003, Journal of Neuroimmunology.
[86] J. Russell,et al. TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation , 2004, Journal of Neuroimmunology.
[87] D. Bonifati,et al. Role of complement in neurodegeneration and neuroinflammation. , 2007, Molecular immunology.
[88] H. Weiner,et al. Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis , 2003, The Journal of experimental medicine.
[89] H. Lassmann,et al. B Lymphocytes Producing Demyelinating Autoantibodies: Development and Function in Gene-targeted Transgenic Mice , 1998, Journal of Neuroimmunology.
[90] Char-Huei Lai,et al. The critical component to establish in vitro BBB model: Pericyte , 2005, Brain Research Reviews.
[91] P. Knopf,et al. Afferent and efferent arms of the humoral immune response to CSF-administered albumins in a rat model with normal blood-brain barrier permeability , 1992, Journal of Neuroimmunology.
[92] B. Becher,et al. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. , 2003, The Journal of clinical investigation.
[93] W. Seaman,et al. Pattern Recognition by TREM-2: Binding of Anionic Ligands1 , 2003, The Journal of Immunology.
[94] J. Phillis,et al. Cyclooxygenases, lipoxygenases, and epoxygenases in CNS: Their role and involvement in neurological disorders , 2006, Brain Research Reviews.
[95] Masami Niwa,et al. Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology , 2005, Cellular and Molecular Neurobiology.
[96] Kathryn J. Jones,et al. CD4-Positive T Cell-Mediated Neuroprotection Requires Dual Compartment Antigen Presentation , 2004, The Journal of Neuroscience.
[97] V. Perry. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation , 1998, Journal of Neuroimmunology.
[98] O. Salonen,et al. CNS manifestations of Nasu–Hakola disease , 2001, Neurology.
[99] V. Sanders,et al. Exacerbation of Facial Motoneuron Loss after Facial Nerve Transection in Severe Combined Immunodeficient (scid) Mice , 1999, The Journal of Neuroscience.
[100] T. Davis,et al. The Blood-Brain Barrier/Neurovascular Unit in Health and Disease , 2005, Pharmacological Reviews.
[101] L. Krubitzer,et al. Nature versus nurture revisited: an old idea with a new twist , 2003, Progress in Neurobiology.
[102] R. Klein,et al. A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. , 2006, The American journal of pathology.
[103] J. Streilein,et al. Systemic Immune Deviation in the Brain That Does Not Depend on the Integrity of the Blood-Brain Barrier1 , 2000, The Journal of Immunology.
[104] J. Sutcliffe,et al. Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia , 2002, Journal of neurochemistry.
[105] C. Carman,et al. A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them , 2004, The Journal of cell biology.
[106] C. Piccirillo,et al. TNF-alpha expression by resident microglia and infiltrating leukocytes in the central nervous system of mice with experimental allergic encephalomyelitis. Regulation by Th1 cytokines. , 1995, Journal of immunology.
[107] Wingerchuk Dm,et al. Multiple sclerosis: epidemiology, genetics, classification, natural history, and clinical outcome measures. , 2000 .
[108] H. Mcdevitt,et al. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. , 1994, Immunity.
[109] W. Hickey,et al. CXC Chemokine Receptor-2 Ligands Are Required for Neutrophil-Mediated Host Defense in Experimental Brain Abscesses1 , 2001, The Journal of Immunology.
[110] J. Baskerville,et al. The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. , 1999, Brain : a journal of neurology.
[111] D. Toomre,et al. Lymphocyte transcellular migration occurs through recruitment of endothelial ICAM-1 to caveola- and F-actin-rich domains , 2006, Nature Cell Biology.
[112] A. Contestabile,et al. Reciprocal Interactions Between Microglia and Neurons: From Survival to Neuropathology , 2002, Reviews in the neurosciences.
[113] S. Miller,et al. Direct Activation of Innate and Antigen-Presenting Functions of Microglia following Infection with Theiler's Virus , 2001, Journal of Virology.
[114] S. Ohtsuki. New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system. , 2004, Biological & pharmaceutical bulletin.
[115] E. Hansson,et al. Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.
[116] Yaniv Ziv,et al. Immune cells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood , 2006, Nature Neuroscience.
[117] H. Cline,et al. Synaptogenesis: A Balancing Act between Excitation and Inhibition , 2005, Current Biology.
[118] A. Zimmerman,et al. Immunity, neuroglia and neuroinflammation in autism , 2005, International review of psychiatry.
[119] S. Akira,et al. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis , 2006, Nature Cell Biology.
[120] E. Ponomarev,et al. CD40 Expression by Microglial Cells Is Required for Their Completion of a Two-Step Activation Process during Central Nervous System Autoimmune Inflammation1 , 2006, The Journal of Immunology.
[121] M. Carson,et al. Integrating innate and adaptive immunity in the whole animal , 1999, Immunological reviews.
[122] Alireza Minagar,et al. Multiple sclerosis as a vascular disease , 2006, Neurological research.
[123] L. Boon,et al. Transfer of Central Nervous System Autoantigens and Presentation in Secondary Lymphoid Organs1 , 2002, The Journal of Immunology.
[124] Steffen Jung,et al. Control of microglial neurotoxicity by the fractalkine receptor , 2006, Nature Neuroscience.
[125] V. Perry,et al. The therapeutic potential of CXC chemokine blockade in acute inflammation in the brain. , 1999, Expert opinion on investigational drugs.
[126] J. Fjell,et al. Lymphoid tissue homing chemokines are expressed in chronic inflammation. , 2000, The American journal of pathology.
[127] U. Dirnagl,et al. Immune surveillance of mouse brain perivascular spaces by blood‐borne macrophages , 2001, The European journal of neuroscience.
[128] P. Lowenstein,et al. Progress and challenges in viral vector-mediated gene transfer to the brain. , 2002, Current opinion in molecular therapeutics.
[129] H. Neumann. Control of glial immune function by neurons , 2001, Glia.
[130] J. Bluestone,et al. How do CD4+CD25+ regulatory T cells control autoimmunity? , 2005, Current opinion in immunology.
[131] A. Stalder,et al. Astrocyte-Targeted Expression of IL-12 Induces Active Cellular Immune Responses in the Central Nervous System and Modulates Experimental Allergic Encephalomyelitis1 , 2000, The Journal of Immunology.
[132] G. Stoll,et al. Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system. , 2002, Advances in experimental medicine and biology.
[133] W. Hickey,et al. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. , 1988, Science.
[134] H. Lei,et al. Intracerebral injection of myelin basic protein (MBP) induces inflammation in brain and causes paraplegia in MBP‐sensitized B6 mice , 1997, Clinical and experimental immunology.
[135] S. Miller,et al. Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection. , 2001, Journal of autoimmunity.
[136] T. Town,et al. Neuronal expression of CD22: Novel mechanism for inhibiting microglial proinflammatory cytokine production , 2004, Glia.